#Adolescent
- The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations
- Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
- Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: Escitalopram vs paroxetine
- Two items on the Hamilton Depression rating scale are effective predictors of remission: Comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine
- Fixed-dose trial of the single isomer SSRI Escitalopram in depressed outpatients